help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

The Oncologist, Vol. 11, No. 4, 375-383, April 2006; doi:10.1634/theoncologist.11-4-375
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferry, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferry, J. A.

Lymphoma Series: Variants of Large-Cell Lymphoma

Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis

Judith A. Ferry

James Homer Wright Pathology Laboratories of the Massachusetts General Hospital and the Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA

Key Words. Burkitt’s lymphoma • Immunophenotype • c-myc • Outcome • Differential diagnosis

Correspondence: Judith A. Ferry, M.D., Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, USA. Telephone: 617-726-3978; Fax: 617-726-7474; e-mail: jferry{at}partners.org

Burkitt’s lymphoma is a highly aggressive lymphoma identified and described in the last century by Denis Burkitt in Africa, in areas endemic for malaria. Since its description in African children, it has been recognized outside areas with endemic malaria, frequently also in children as well as among individuals with an underlying immunodeficiency. Since its initial designation as Burkitt’s lymphoma, this type of lymphoma and lymphomas closely resembling it have received a variety of names in different classifications of lymphomas and leukemias: undifferentiated lymphoma, Burkitt’s and non-Burkitt’s type in the modified Rappaport Classification, malignant lymphoma, small non-cleaved cell, Burkitt’s type in the Working Formulation, Burkitt’s lymphoma and high-grade B-cell lymphoma, Burkitt-like in the REAL Classification, and acute lymphoblastic leukemia, L3 type in the FAB Classification. With the publication of the WHO Classification of Haematopoietic and Lymphoid Tumors, the nomenclature of this lymphoma has come full circle, and it is once again known simply as Burkitt’s lymphoma. In recent years, efforts have focused on improving therapy for this rapidly proliferating neoplasm while minimizing, to the extent possible, treatment-associated toxicity. These efforts have led to the development of high-intensity, short-duration combination chemotherapy that has proven extremely effective for a high proportion of Burkitt’s lymphoma patients. The differential diagnosis of Burkitt’s lymphoma is broad, and precise diagnosis based on histologic, immunophenotypic, and genetic features remains the critical first step in planning appropriate therapy.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
H C Moore, K M Wood, M S Jackson, M A Lastowska, D Hall, H Imrie, C P F Redfern, P E Lovat, F Ponthan, K O'Toole, et al.
Histological profile of tumours from MYCN transgenic mice
J. Clin. Pathol., October 1, 2008; 61(10): 1098 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
G Brady, G J MacArthur, and P J Farrell
Epstein-Barr virus and Burkitt lymphoma
Postgrad. Med. J., July 1, 2008; 84(993): 372 - 377.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
P. R. Bhosale, M. Patnana, C. Viswanathan, and J. Szklaruk
The Inguinal Canal: Anatomy and Imaging Features of Common and Uncommon Masses
RadioGraphics, May 1, 2008; 28(3): 819 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Brady, G J MacArthur, and P J Farrell
Epstein Barr virus and Burkitt lymphoma
J. Clin. Pathol., December 1, 2007; 60(12): 1397 - 1402.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Maecker, T. Jack, M. Zimmermann, H. Abdul-Khaliq, M. Burdelski, A. Fuchs, P. Hoyer, S. Koepf, U. Kraemer, G. F. Laube, et al.
CNS or Bone Marrow Involvement As Risk Factors for Poor Survival in Post-Transplantation Lymphoproliferative Disorders in Children After Solid Organ Transplantation
J. Clin. Oncol., November 1, 2007; 25(31): 4902 - 4908.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2006 by AlphaMed Press.